VisionTech Partners’ portfolio company NeuroFx may have an effective treatment for stroke. The Indy-based company just cleared an important hurdle with the FDA toward its first clinical trials in humans.
Keith Davis is not your ordinary angel investor. He’s the director of the Johnson Center for Innovation and Translational Research at Indiana University (IU) Bloomington, a senior research scientist in IU’s Biotechnology Program, and an entrepreneur himself.
August 25, 2016
Ben Pidgeon has joined VisionTech Partners/VisionTech Angels as executive director. Pidgeon is a 15-year banking executive and president of the Indiana Venture Club.
Your palms are sweaty. Your legs are shaking. You can’t get the words out of your mouth fast enough. Finally, (continued…)
By Don Scifres VisionTech Partners is where inventors, entrepreneurs, investors, universities, and strategic partners converge to share, develop, fund, and (continued…)